Broker-Dealers on SEC Form D for RAYMOND JAMES & ASSOCIATES, INC.

Search by Recipient Name or Primary Issuer:

Displaying 501-510 out of 972 results

Recipient	CRD	Primary Issuer	CIK	Filing Date	Form Type	Total Offering Amount	Total Amount Sold
RAYMOND JAMES & ASSOCIATES, INC.	705	P2 Capital Fund, Ltd.	1409505	12/14/2018	D/A	Indefinite	$109,648,000
RAYMOND JAMES & ASSOCIATES, INC.	705	EAGLE GROWTH PARTNERS II, LP	1415629	01/22/2018	D/A	Indefinite	$108,724,664
RAYMOND JAMES & ASSOCIATES, INC.	705	EAGLE GROWTH PARTNERS II, LP	1415629	02/12/2019	D/A	Indefinite	$108,724,664
RAYMOND JAMES & ASSOCIATES, INC.	705	EAGLE GROWTH PARTNERS II, LP	1415629	02/11/2020	D/A	Indefinite	$108,724,664
RAYMOND JAMES & ASSOCIATES, INC.	705	EAGLE GROWTH PARTNERS II, LP	1415629	02/02/2021	D/A	Indefinite	$108,724,664
RAYMOND JAMES & ASSOCIATES, INC.	705	EAGLE GROWTH PARTNERS II, LP	1415629	01/26/2022	D/A	Indefinite	$108,724,664
RAYMOND JAMES & ASSOCIATES, INC.	705	EAGLE GROWTH PARTNERS II, LP	1415629	01/30/2023	D/A	Indefinite	$108,724,664
RAYMOND JAMES & ASSOCIATES, INC.	705	EAGLE GROWTH PARTNERS II, LP	1415629	02/01/2017	D/A	Indefinite	$107,575,764
RAYMOND JAMES & ASSOCIATES, INC.	705	Carlyle Private Equity Access Fund 2014, L.P.	1624393	06/17/2015	D/A	Indefinite	$107,479,000
RAYMOND JAMES & ASSOCIATES, INC.	705	ZIOPHARM ONCOLOGY INC	1107421	08/09/2019	D	$105,106,064	$105,106,064